{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:41:23Z","timestamp":1791618083488,"version":"4.3.4"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["10.46540\/4308-00130B"],"award-info":[{"award-number":["10.46540\/4308-00130B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>Does livebirth probability differ between women diagnosed with breast cancer and unaffected women and is it impacted by age at diagnosis, time trends, parity, partnership status, and the presence of lymph node metastases and distant metastases?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>Livebirth probability was significantly reduced in 5940 women diagnosed with breast cancer aged 18\u201340\u2009years during 1968\u20132016 compared to 1\u00a0126\u00a0478 age-matched unaffected women, particularly among women with higher diagnosis age, parity\u2009\u2265\u20091, marriage, and the presence of nodal involvement and distant metastases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>The survival rate for women diagnosed with breast cancer has increased over the recent decades, and in Denmark, the 5-year survival rate for women diagnosed &amp;lt;50\u2009years of age was 92.2% in 2022. Chemotherapy can damage the ovarian reserve, resulting in premature ovarian insufficiency and infertility. The age of first-time mothers is increasing, and many women have not yet completed family building at the time of diagnosis. Consequently, greater focus is now placed on quality-of-life following breast cancer, including the possibility of survivors to have children. Studies have shown a decreased fertility rate in women diagnosed with cancer during their reproductive lifespan, however, studies specifically focusing on the probability of livebirth in women previously diagnosed with breast cancer are scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>This is a national, register-based cohort study including women diagnosed with breast cancer from the Danish Cancer Register between 1968 and 2016, aged 18\u201340\u2009years at time of diagnosis (n\u2009=\u20095940). Each woman was randomly matched with \u223c190 unaffected women from the background population according to the age at diagnosis (n\u2009=\u20091\u00a0126\u00a0478). The women were followed in medical and sociodemographic national population registers until childbirth, death, immigration, or end of study (31 December 2018).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                    <jats:p>In all analyses, we compared the probability of livebirth between women diagnosed with breast cancer and the age-matched comparison group. Analyses were stratified by parity- and partnership status at diagnosis, age-group at diagnosis, and year of diagnosis. Stratified analyses on the probability of livebirth were conducted for women with lymph-node metastases and distant metastases at the time of diagnosis. Analyses were adjusted for age, year of diagnosis, parity, educational level, and migration status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>The study population consisted of 5940 women aged 18\u201340\u2009years at diagnosis of breast cancer between 1968 and 2016 and 1\u00a0126\u00a0478 women in the age-matched comparison group. Breast cancer survivors had a significantly lower probability of livebirth than the age-matched comparison group (aHR 0.38 [95% CI 0.35\u20130.41]); negatively impacted by increasing age at diagnosis (35\u201340\u2009years: aHR 0.34 [95% CI 0.28\u20130.40], 18\u201324\u2009years: 0.66 [95% CI 0.46\u20130.95]), parity \u22651 (parous: aHR 0.31 [95% CI 0.27\u20130.35], nulliparous: 0.51 [95% CI 0.45\u20130.59]), and marriage (married: aHR 0.31 [95% CI 0.27\u20130.36], single 0.53 [95% CI 0.45\u20130.63]). Being diagnosed in recent decades increased the probability of livebirth in nulliparous women; however, the same association was not found for parous women. Among women with nodal involvement (48%) and distant metastases (3%), the probability of livebirth compared to unaffected women was aHR 0.30 [95% CI 0.26\u20130.35] and 0.18 [95% CI 0.08\u20130.42], respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>We did not have information on whether the women desired children or whether they underwent fertility preservation (FP) prior to receiving gonadotoxic treatment. For women diagnosed in the most recent decades, the follow-up time was limited. Information on tamoxifen treatment for estrogen receptor-positive tumors could have been relevant, as it likely delays pregnancy and consequently reduces conception probability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                    <jats:p>Our results highlight the continued importance of onco-fertility counseling and FP in young women diagnosed with breast cancer, particularly among women diagnosed toward the end of their reproductive lifespan and those with the presence of lymph node metastases and distant metastases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                    <jats:p>The study is funded by the Independent Research Fund Denmark (Grant ID 10.46540\/4308-00130B). Anja Pinborg has received grants (payment to institution) and consultancy fees from Gedeon Richter, Ferring Pharmaceuticals, Merck A\/S, and Cryos; honoraria from Gedeon Richter, Ferring Pharmaceuticals, Merck A\/S, and Organon; and support for attending meetings and\/or travel (payment to institution) from Gideon Richter. These companies had no role in the study. The remaining authors have no conflicts or interests to declare.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>N\/A.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humrep\/deaf192","type":"journal-article","created":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T11:36:46Z","timestamp":1757849806000},"page":"2430-2439","source":"Crossref","is-referenced-by-count":2,"title":["Livebirth among 5940 Danish women diagnosed with breast cancer at age 18\u201340\u00a0years between 1968 and 2016: a register-based cohort study"],"prefix":"10.1093","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7249-5442","authenticated-orcid":false,"given":"Anna Mathilde","family":"Yde","sequence":"first","affiliation":[{"name":"The Fertility Clinic, Department of Gynaecology, Fertility and Obstetrics, Copenhagen University Hospital, Rigshospitalet , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte Berdiin","family":"Colmorn","sequence":"additional","affiliation":[{"name":"The Fertility Clinic, Department of Gynaecology, Fertility and Obstetrics, Copenhagen University Hospital, Rigshospitalet , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8340-104X","authenticated-orcid":false,"given":"Anja","family":"Pinborg","sequence":"additional","affiliation":[{"name":"The Fertility Clinic, Department of Gynaecology, Fertility and Obstetrics, Copenhagen University Hospital, Rigshospitalet , Copenhagen,","place":["Denmark"]},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9518-1734","authenticated-orcid":false,"given":"Lone","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Section of Social Medicine, Department of Public Health, Faculty of Medical and Health Sciences, University of Copenhagen , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Kroman","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Herlev and Gentofte Hospital , Gentofte,","place":["Denmark"]},{"name":"Danish Cancer Society , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik Nikolaj","family":"Kyhl","sequence":"additional","affiliation":[{"name":"The Fertility Clinic, Department of Gynaecology, Fertility and Obstetrics, Copenhagen University Hospital, Rigshospitalet , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditte","family":"Vassard","sequence":"additional","affiliation":[{"name":"The Fertility Clinic, Department of Gynaecology, Fertility and Obstetrics, Copenhagen University Hospital, Rigshospitalet , Copenhagen,","place":["Denmark"]},{"name":"Section of Social Medicine, Department of Public Health, Faculty of Medical and Health Sciences, University of Copenhagen , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten Tryde","family":"Macklon","sequence":"additional","affiliation":[{"name":"The Fertility Clinic, Department of Gynaecology, Fertility and Obstetrics, Copenhagen University Hospital, Rigshospitalet , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"2025120400520166500_deaf192-B1","doi-asserted-by":"crossref","first-page":"hoaa052","DOI":"10.1093\/hropen\/hoaa052","article-title":"ESHRE guideline: female fertility preservation","volume":"2020","author":"Anderson","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2025120400520166500_deaf192-B2","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/humrep\/dey216","article-title":"The impact of cancer on subsequent chance of pregnancy: a population-based analysis","volume":"33","author":"Anderson","year":"2018","journal-title":"Hum Reprod"},{"key":"2025120400520166500_deaf192-B3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/humupd\/dmac004","article-title":"Anti-M\u00fcllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review","volume":"28","author":"Anderson","year":"2022","journal-title":"Hum Reprod Update"},{"key":"2025120400520166500_deaf192-B4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2407-13-30","article-title":"A population-based study of rates of childbirth in recurrence-free female young adult survivors of non-gynecologic malignancies","volume":"13","author":"Baxter","year":"2013","journal-title":"BMC Cancer"},{"key":"2025120400520166500_deaf192-B5123067","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-024-01720-1","article-title":"Impact of cancer during reproductive age on the probability of livebirth after cancer: a register-based cohort study among Danish women aged 18-39 with and without cancer","author":"Bentsen","year":"2024","journal-title":"J Cancer Surviv"},{"key":"2025120400520166500_deaf192-B5","first-page":"421","article-title":"Thoughts about fertility among female adolescents and young adults with cancer: a qualitative study","volume":"31","author":"Bentsen","year":"2023","journal-title":"Support Care Cancer"},{"key":"2025120400520166500_deaf192-B6","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/humrep\/dey229","article-title":"Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve","volume":"33","author":"Berg","year":"2018","journal-title":"Hum Reprod"},{"key":"2025120400520166500_deaf192-B7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10549-012-2269-0","article-title":"Breast cancer incidence by estrogen receptor status in Denmark from 1996 to 2007","volume":"136","author":"Bigaard","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"2025120400520166500_deaf192-B8","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMra1614676","article-title":"Fertility preservation in women","volume":"377","author":"Donnez","year":"2017","journal-title":"N Engl J Med"},{"key":"2025120400520166500_deaf192-B9","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1200\/JCO.2017.76.3441","article-title":"Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review","volume":"36","author":"Dorp","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025120400520166500_deaf192-B10","author":"Fertility Statistics\u2014Statistics Explained"},{"key":"2025120400520166500_deaf192-B11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12978-022-01559-8","article-title":"Premature ovarian insufficiency in female adolescent and young adult survivors of non-gynecological cancers: a population-based cohort study","volume":"20","author":"Flatt","year":"2023","journal-title":"Reprod Health"},{"key":"2025120400520166500_deaf192-B12","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.ejca.2015.05.007","article-title":"Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome","volume":"51","author":"Goldrat","year":"2015","journal-title":"Eur J Cancer"},{"key":"2025120400520166500_deaf192-B13","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/cncr.27929","article-title":"Birth rates among female cancer survivors","volume":"119","author":"Hartman","year":"2013","journal-title":"Cancer"},{"key":"2025120400520166500_deaf192-B14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/jnci\/djr541","article-title":"Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review","volume":"104","author":"Howard-Anderson","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"2025120400520166500_deaf192-B15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(97)03052-3","article-title":"Should women be advised against pregnancy after breast-cancer treatment?","volume":"350","author":"Kroman","year":"1997","journal-title":"Lancet"},{"key":"2025120400520166500_deaf192-B16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/02841860801935491","article-title":"Pregnancy after treatment of breast cancer\u2014a population-based study on behalf of Danish Breast Cancer Cooperative Group","volume":"47","author":"Kroman","year":"2008","journal-title":"Acta Oncol"},{"key":"2025120400520166500_deaf192-B17","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1200\/JCO.21.00535","article-title":"Pregnancy after breast cancer: a systematic review and meta-analysis","volume":"39","author":"Lambertini","year":"2021","journal-title":"J Clin Oncol"},{"key":"2025120400520166500_deaf192-B18","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1210\/jc.2003-030352","article-title":"Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer","volume":"88","author":"Larsen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2025120400520166500_deaf192-B19","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1111\/jan.16450","article-title":"Latent profiles of fear of cancer recurrence in breast cancer patients of reproductive age and associations with reproductive concerns","volume":"81","author":"Liu","year":"2025","journal-title":"J Adv Nurs"},{"key":"2025120400520166500_deaf192-B20","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/humrep\/deac225","article-title":"Determinants of transplantation success with cryopreserved ovarian tissue: data from 196 women of the FertiPROTEKT network","volume":"37","author":"Lotz","year":"2022","journal-title":"Hum Reprod"},{"key":"2025120400520166500_deaf192-B21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/jamaoncol.2020.5957","article-title":"Reproductive outcomes after breast cancer in women with vs without fertility preservation","volume":"7","author":"Marklund","year":"2021","journal-title":"JAMA Oncol"},{"key":"2025120400520166500_deaf192-B22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0303-7207(00)00365-8","article-title":"Reproduction post-chemotherapy in young cancer patients","volume":"169","author":"Meirow","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"2025120400520166500_deaf192-B23","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.fertnstert.2022.03.004","article-title":"A comparison of fertility preservation outcomes in patients who froze oocytes, embryos, or ovarian tissue for medically indicated circumstances: a systematic review and meta-analysis","volume":"117","author":"N\u00ed Dhonnabh\u00e1in","year":"2022","journal-title":"Fertil Steril"},{"key":"2025120400520166500_deaf192-B24","author":"NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 9.4 (29.08.2024). Association of the Nordic Cancer Registries. Cancer Registry of Norway, 2024."},{"key":"2025120400520166500_deaf192-B25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/CCO.0000000000000977","article-title":"Ovarian stimulation and oocyte cryopreservation in females with cancer","volume":"35","author":"Oktay","year":"2023","journal-title":"Curr Opin Oncol"},{"key":"2025120400520166500_deaf192-B26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ctrv.2016.11.006","article-title":"Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: a systematic review","volume":"53","author":"Overbeek","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"2025120400520166500_deaf192-B27","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1200\/JCO.2004.01.159","article-title":"Web-based survey of fertility issues in young women with breast cancer","volume":"22","author":"Partridge","year":"2004","journal-title":"J Clin Oncol"},{"key":"2025120400520166500_deaf192-B28","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa2212856","article-title":"Interrupting endocrine therapy to attempt pregnancy after breast cancer","volume":"388","author":"Partridge","year":"2023","journal-title":"N Engl J Med"},{"key":"2025120400520166500_deaf192-B29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10549-009-0401-6","article-title":"The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review","volume":"116","author":"Peate","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"2025120400520166500_deaf192-B30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.rbmo.2010.10.015","article-title":"Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique","volume":"22","author":"Rosendahl","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"2025120400520166500_deaf192-B31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.rbmo.2012.12.001","article-title":"Fertility in cancer patients after cryopreservation of one ovary","volume":"26","author":"Schmidt","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"2025120400520166500_deaf192-B32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00404-017-4594-3","article-title":"Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: indications for fertility preservation","volume":"297","author":"Sch\u00fcring","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"2025120400520166500_deaf192-B33","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1200\/JCO-24-02782","article-title":"Fertility preservation in people with cancer: ASCO guideline update","volume":"43","author":"Su","year":"2025","journal-title":"J Clin Oncol"},{"key":"2025120400520166500_deaf192-B34","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S1470-2045(24)00269-9","article-title":"Risks of adverse obstetric outcomes among female survivors of adolescent and young adult cancer in England (TYACSS): a population-based, retrospective cohort study","volume":"25","author":"Sunguc","year":"2024","journal-title":"Lancet Oncol"},{"key":"2025120400520166500_deaf192-B35","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/humrep\/deab036","article-title":"Risk of infertility in female adolescents and young adults with cancer: a population-based cohort study","volume":"36","author":"Velez","year":"2021","journal-title":"Hum Reprod"},{"key":"2025120400520166500_deaf192-B36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10549-020-05598-2","article-title":"Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience","volume":"181","author":"Vriens","year":"2020","journal-title":"Breast Cancer Res Treat"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/40\/12\/2430\/64465289\/deaf192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/40\/12\/2430\/64465289\/deaf192.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T05:52:11Z","timestamp":1764827531000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/40\/12\/2430\/8270787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,10,1]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deaf192","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,10,1]]}}}